Medical device company Intuitive Surgical, Inc. (NASDAQ: ISRG) announced operating results for the first quarter of 2024, reporting higher revenues and adjusted
Categories
Medical Devices
Key takeaways from Johnson & Johnson’s (JNJ) Q1 2024 earnings report
Over the years, Johnson & Johnson (NYSE: JNJ) has constantly ramped up its portfolio and pipeline. After spinning off the consumer health
ANGO Earnings: Highlights of AngioDynamics’ Q3 2024 results
AngioDynamics Inc. (NASDAQ: ANGO) has reported a wider net loss for the third quarter of 2024 when the medical device maker's revenue
Earnings Summary: CooperCompanies (COO) reports strong Q1 2024 results
Medical device maker CooperCompanies (NYSE: COO) announced financial results for the first quarter of 2024, reporting an increase in revenues and adjusted
Earnings Summary: Dentsply Sirona reports higher sales for Q4 2023
Dentsply Sirona Inc. (NASDAQ: XRAY), a leading manufacturer of professional dental products and technologies, reported fourth-quarter 2023 financial results, reporting an increase
Earnings: Agilent’s (A) Q1 2024 profit declines on lower revenues
Healthcare company Agilent Technologies Inc. (NYSE: A) reported a decrease in adjusted earnings for the first quarter of 2024 when its revenues
Medtronic (MDT) Q3 2024 revenue rises 5%; adj. earnings flat
Medical device maker Medtronic plc (NYSE: MDT) reported an increase in revenues for the third quarter of 2024 when the company's adjusted
Earnings Summary: Baxter International reports higher Q4 sales and adj. profit
Medical device maker Baxter International Inc. (NYSE: BAX) has announced financial results for the fourth quarter of 2023, reporting higher revenues and
Thermo Fisher Scientific (TMO) Q4 adj. earnings rise; revenue down 5%
Thermo Fisher Scientific Inc. (NYSE: TMO) on Wednesday announced fourth-quarter 2023 financial results, reporting higher adjusted earnings, despite a decrease in revenues.
ANGO Earnings: A snapshot of AngioDynamics’ Q2 2024 results
AngioDynamics Inc. (NASDAQ: ANGO) on Wednesday reported a net loss, on an adjusted basis, for the second quarter of 2024 when its
Earnings Summary: Highlights of CooperCompanies’ (COO) Q4 2023 financial results
Medical device maker CooperCompanies (NYSE: COO) announced financial results for the fourth quarter of 2023, reporting an increase in revenues and adjusted
Johnson & Johnson (JNJ) focuses on innovation after separating consumer business
Healthcare conglomerate Johnson & Johnson (NYSE: JNJ) recently raised its full-year guidance to reflect the strong performance of the pharmaceutical and medical
Medtronic (MDT) Q2 2024 adj. earnings decline despite revenue growth
Medical device maker Medtronic plc (NYSE: MDT) reported a decline in adjusted earnings for the second quarter of 2024, despite an increase
Earnings Summary: Becton, Dickinson, and Company reports Q4 2023 results
Medical technology company Becton, Dickinson, and Company (NYSE: BDX) announced results for the final three months of fiscal 2023. Fourth-quarter revenue increased
Earnings Summary: A snapshot of Zimmer Biomet Holdings’ Q3 2023 results
Medical technology company Zimmer Biomet Holdings, Inc. (NYSE: ZBH) on Tuesday reported an increase in third-quarter sales and adjusted profit. Third-quarter net
ISRG Earnings: Intuitive Surgical Q3 2023 revenues and earnings increase
Medical device company Intuitive Surgical, Inc. (NASDAQ: ISRG) announced operating results for the third quarter of 2023, reporting higher revenues and adjusted
Intuitive Surgical Q3 2023 Earnings: Stay tuned for the live earnings call and real-time transcript
Medical device maker Intuitive Surgical, Inc. (NASDAQ: ISRG) will be reporting its third-quarter 2023 results today after the closing bell. Listen to
Infographic: AngioDynamics reports adjusted loss for Q1 2024; sales down 4%
AngioDynamics Inc. (NASDAQ: ANGO) on Wednesday reported a net loss, on an adjusted basis, for the first quarter of 2024 when its
Petros Pharma is focused on establishing mechanisms for Rx-to-OTC switch: CCO Fady Boctor
Petros Pharmaceuticals, Inc. (NASDAQ: PTPI) is a pharma company focused on identifying, developing, and commercializing therapeutics for men's health issues. It operates
Earnings Summary: Here’s how CooperCompanies (COO) performed in Q3 2023
Medical device maker CooperCompanies (NYSE: COO) announced financial results for the third quarter of 2023, reporting an increase in revenues. Third-quarter revenue
Medtronic PLC Q1 2024 Earnings Conference Call Insights
Key highlights from Medtronic PLC (MDT) Q1 2024 Earnings Concall Management Update: [00:04:08] MDT is focusing its R&D investments on technology megatrends